ResearcherWenzhou Medical UniversityActive in the last 2 years
Wei Mei Guo
Matched on ORCID iD 0000-0002-8560-6700; OpenAlex author ID A5077758642. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 6
2023: 1 paper · 2024: none · 2025: 1 paper
Papers 2
- ZDHHC9-mediated CD38 palmitoylation stabilizes CD38 expression and promotes pancreatic cancer growth. Last author DOI 10.1038/s42003-025-07897-0↗
- Targeting ZDHHC9 potentiates anti-programmed death-ligand 1 immunotherapy of pancreatic cancer by modifying the tumor microenvironment. Co-author DOI 10.1016/j.biopha.2023.114567↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hui Guo · 2 shared papers, 2023–2025 · strength 0.42
- Paper ZDHHC9-mediated CD38 palmitoylation stabilizes CD38 expression and promotes pancreatic cancer growth. DOI 10.1038/s42003-025-07897-0↗
- Paper Targeting ZDHHC9 potentiates anti-programmed death-ligand 1 immunotherapy of pancreatic cancer by modifying the tumor m… DOI 10.1016/j.biopha.2023.114567↗
- Zhiqing Lin · 2 shared papers, 2023–2025 · strength 0.42
- Paper ZDHHC9-mediated CD38 palmitoylation stabilizes CD38 expression and promotes pancreatic cancer growth. DOI 10.1038/s42003-025-07897-0↗
- Paper Targeting ZDHHC9 potentiates anti-programmed death-ligand 1 immunotherapy of pancreatic cancer by modifying the tumor m… DOI 10.1016/j.biopha.2023.114567↗
- Xin Liu · 1 shared paper, 2023 · strength 0.15
- Peng Zhang · 1 shared paper, 2023 · strength 0.15
- Jianmin Wu · 1 shared paper, 2023 · strength 0.15
- Keke Huang · 1 shared paper, 2023 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.